Overview

Location [1]
5q35.1
Pathway
DNA damage/repair
Protein [2]
Nucleophosmin
Synonyms [1]
NPM, B23

Nucleophosmin (NPM1, also known as nuclear phosphoprotein B23, numatrin) is a gene that encodes a phosphoprotein, which is involved in the regulation of the interactions of ARF and p53. Fusions, missense mutations, nonsense mutations, frameshift insertions and deletions, and in-frame deletions and insertions are observed in cancers such as acute myeloid leukemia and skin cancer.

NPM1 is altered in 0.86% of all cancers with leukemia, non-small cell lung carcinoma, colorectal adenocarcinoma, breast carcinoma, and melanoma having the greatest prevalence of alterations [3].

NPM1 GENIE Cases - Top Diseases

The most common alterations in NPM1 are NPM1 Mutation (1.00%), NPM1 W288Cfs*12 (0.61%), NPM1 Amplification (0.08%), NPM1 Loss (0.04%), and NPM1 L287Ffs*13 (0.03%) [3].

NPM1 GENIE Cases - Top Alterations

Significance of NPM1 in Diseases

Acute Myeloid Leukemia +

Myelodysplastic Syndromes +

Acute Lymphoblastic Leukemia +

Chronic Myelomonocytic Leukemia +

Malignant Solid Tumor +

Chronic Myeloid Leukemia +

Prostate Adenocarcinoma +

Mantle Cell Lymphoma +

Non-Hodgkin Lymphoma +

Acute Leukemia +

Anaplastic Large Cell Lymphoma +

Hodgkin Lymphoma +

Multiple Myeloma +

Myeloproliferative Neoplasm +

Breast Carcinoma +

Prostate Carcinoma +

Burkitt Lymphoma +

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma +

Follicular Lymphoma +

Marginal Zone Lymphoma +

Ovarian Carcinoma +

Myelodysplastic/Myeloproliferative Neoplasm +

Diffuse Large B-Cell Lymphoma +

Chronic Lymphocytic Leukemia +

Colorectal Carcinoma +

Lymphoplasmacytic Lymphoma +

Myelofibrosis +

Refractory Anemia With Excess Blasts +

Small Cell Lung Carcinoma +

Urothelial Carcinoma +

Gastric Carcinoma +

Lymphoma +

Acute Promyelocytic Leukemia +

Adenocarcinoma Of The Gastroesophageal Junction +

B-Cell Non-Hodgkin Lymphoma +

Cervical Carcinoma +

Cholangiocarcinoma +

Lymphoblastic Lymphoma +

Mature T-Cell And NK-Cell Neoplasm +

Prolymphocytic Leukemia +

Refractory Anemia With Excess Blasts-2 +

Hematopoietic And Lymphoid Malignancy +

Anal Carcinoma +

Uveal Melanoma +

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma +

Bladder Carcinoma +

Clear Cell Renal Cell Carcinoma +

Endometrial Carcinoma +

High Grade Ovarian Serous Adenocarcinoma +

Lung Adenocarcinoma +

Non-Small Cell Lung Carcinoma +

Squamous Cell Lung Carcinoma +

Soft Tissue Sarcoma +

Head And Neck Squamous Cell Carcinoma +

Pancreatic Adenocarcinoma +

Pancreatic Carcinoma +

Acute Biphenotypic Leukemia +

Acute Myeloid Leukemia With Myelodysplasia-Related Changes +

B-Cell Prolymphocytic Leukemia +

Blastic Plasmacytoid Dendritic Cell Neoplasm +

Chronic Myelomonocytic Leukemia-1 +

Fallopian Tube Carcinoma +

Histiocytic And Dendritic Cell Neoplasm +

Mature B-Cell Lymphoma/Leukemia +

Mediastinal Large B-Cell Lymphoma +

Mesothelioma +

Myeloid Sarcoma +

Penile Carcinoma +

Peritoneal Carcinoma +

Plasma Cell Leukemia +

Primary Myelofibrosis +

Refractory Anemia +

Refractory Anemia With Ring Sideroblasts +

Richter Syndrome +

Small Lymphocytic Leukemia +

T-Cell Lymphoblastic Leukemia/Lymphoma +

T-Cell Non-Hodgkin Lymphoma +

T-Cell And NK-Cell Neoplasm +

Therapy-Related Myeloid Neoplasm +

Vaginal Carcinoma +

Vulvar Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.